scholarly journals ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE G894T POLYMORPHISM IN PATIENTS WITH CORONARY HEART DISEASE AND DIABETES MELLITUS TYPE 2

2018 ◽  
Vol 16 (6) ◽  
pp. 673-678
Author(s):  
E. V. Davydchyk ◽  
◽  
V. A. Snezhitskiy ◽  
T. L. Stepuro ◽  
L. V. Nikonova ◽  
...  
Keyword(s):  
Nitric Oxide ◽  
Diabetes Mellitus ◽  
Coronary Heart Disease ◽  
Heart Disease ◽  
Endothelial Nitric Oxide Synthase ◽  
Diabetes Mellitus Type 2 ◽  
Oxide Synthase ◽  
Endothelial Nitric Oxide ◽  
G894t Polymorphism

scholarly journals Metformin and vildagliptin combination: A new approach of endothelial nitric oxide synthase activity regulation and metabolism in diabetes mellitus type 2

2018 ◽  
Vol 16 (2) ◽  
pp. 5-12
Author(s):  
Aleksandr L Urakov ◽  
Konstantin G Gurevich ◽  
Iuliia A Sorokina ◽  
Liubov V Lovtsova ◽  
Olga V Zanozina ◽  
...  
Keyword(s):  
Nitric Oxide ◽  
Diabetes Mellitus ◽  
Endothelial Nitric Oxide Synthase ◽  
Diabetes Mellitus Type 2 ◽  
Activity Regulation ◽  
New Approach ◽  
Oxide Synthase ◽  
Endothelial Nitric Oxide ◽  
Nitric Oxide Synthase Activity

This review analyzes the research results of additional effects and mechanisms of action of sugar-reducing drugs. Hence it has been suggested that asymmetric dimethylarginine may be a target molecule for metformin, vildagliptin, and combinations thereof. (For citation: Urakov AL, Gurevich KG, Sorokina IA, et al. Metformin and vildagliptin combination: a new approach of endothelial nitric oxide synthase activity regulation and metabolism in diabetes mellitus type 2. Reviews on Clinical Pharmacology and Drug Therapy. 2018;16(2):5-12. doi: 10.17816/RCF1625-12).

Sign in / Sign up

Export Citation Format

Share Document